VALERIE DURNEY: Open Payments
NPI 1336236702 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,435 in 72 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,760 · 2025 $2,435
Food & beverage: $1,629Consulting: $630Education: $134Travel & lodging: $42
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $1,109 |
| AstraZeneca Pharmaceuticals LP | 17 | $466 |
| GlaxoSmithKline, LLC. | 27 | $436 |
| Viatris Specialty LLC | 6 | $120 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Verona Pharma, Inc. | 3 | $69 |
| Amgen Inc. | 2 | $56 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Baxter Healthcare | 1 | $18 |
Products named: NUCALA, DUPIXENT, BREZTRI, FASENRA, YUPELRI, AIRSUPRA, TEZSPIRE, TRELEGY ELLIPTA.
Industry payments across MA — which companies pay providers there.
